Vascular Grafts Market Size, Share & Trends Analysis Report By Product (Hemodialysis Access Grafts, Endovascular Stent Grafts), By Application, By Raw Material, By Region- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2024-2033

The global vascular grafts market size was exhibited at USD 1.80 billion in 2023 and is projected to hit around USD 3.61 billion by 2033, growing at a CAGR of 7.2% during the forecast period of 2024 to 2033.

Key Takeaways:

• In 2023, the endovascular stent-grafts product segment dominated the market with a share of 63.8%.
• In 2023, the cardiac aneurysm segment held the largest market share at 51.9%.
• The polytetrafluoroethylene segment held a market revenue share of 47.0% in 2023.
• North America held the largest market share of 31.0% in 2023, owing to the rising health awareness and availability of health care facilities for cardiovascular treatment in the region.

Vascular Grafts Market Report Scope

Key factors driving market growth include the increasing number of dialysis procedures and rising chronic kidney disease (CKD) cases globally. Worldwide, over 2 million people receive treatment for dialysis. Around 37 million people in the U.S. and 3 million people are estimated to suffer from CKD. Moreover, the prevalence of cardiovascular diseases, diabetes, and end-stage renal disease is also expected to drive the market. Cardiovascular disease (CVD) is the leading cause of death in the U.S., and according to the data published by World Health Organization, an estimated 17.9 million people died due to CVD in 2019.

Moreover, the rising healthcare expenditure, availability of reimbursement policies, and rising demand for products with technological advancements are expected to offer multiple opportunities for market growth during the forecast period. Technological advancement is fostering the development of next-generation tissue-engineered vascular grafts to treat various vasculopathies. This technique rationally addresses critical challenges like intimal hyperplasia, thrombosis, and constructive graft remodeling.

Also, with the increasing demand for minimally invasive procedures, the adoption of MIDCAB procedure has risen, as it is safe and has a low mortality rate. Also, it is compatible with aortic cross-clamp and cardiopulmonary bypass. Furthermore, the advancement in surgical procedures using coronary artery stent grafts is anticipated to impel the demand for vascular grafts in upcoming years.

The outbreak of COVID-19 had a negative impact on the vascular grafts market due to disruptions in operations, supply chains, distribution systems, etc. Also, with the intent of controlling the spread of coronavirus, many elective procedures were canceled or postponed. Also, the healthcare professionals were focusing on COVID-19 treatment, which declined the number of other non-essential surgeries. This resulted in a decline in revenue. For instance, in 2020, the cardiac and vascular group of Medtronic plc’s witnessed a 9.0% decrease in revenue as compared to 2019.

The extensive use of prosthetic grafts such as electrospun polyurethane vascular grafts for complex vascular trauma as they reduce the risk of neointimal formation is expected to propel the market over the forecast period.

Furthermore, market players focusing on the introduction of innovative products are adding fuel to market growth. For instance, in September 2023, Terumo Aortic launched PANTHER, a global surgical graft study of knitted and woven surgical grafts. Also, strategies such as mergers & acquisitions, collaborations, and partnerships adopted by key players to expand and strengthen the market are propelling growth.

Product Insights

In 2023, the endovascular stent-grafts product segment dominated the market with a share of 63.8%. The rising adoption of endovascular stent-grafts to treat aneurysms, including thoracic aortic aneurysms, is the major factor contributing to market growth. However, these endovascular stents, - grafts, are specially used for the treatment of abdominal aortic aneurysm (AAA), thereby impelling the growth.

Also, the mycotic aneurysm can be treated using these stent grafts in combination with antibiotics. Moreover, a shift towards EVAR rather than conventional open thoracic aorta surgeries and the technical development of endovascular applications is expected to raise the demand for endovascular stents and grafts. Furthermore, endovascular grafts help to recover fast and are less painful when compared to open surgeries of the chest. Also, it results in reduced hospital stays, thereby increasing its adoption.

However, the peripheral vascular grafts segment is expected to witness the fastest growth during the forecast period owing to the rising rate of renal failure and hardening of arteries. In addition, technological advancements in the development of products to treat peripheral artery disease is expected to impel segment growth over a forecast period.

Application Insights

In 2023, the cardiac aneurysm segment held the largest market share of 51.9% owing to the rising prevalence of high blood pressure, rising cholesterol levels, sedentary lifestyle, and growing geriatric population. Also, congenital heart surgeries carried out using advanced tissue-engineered grafts are fostering segment growth. Moreover, the increasing incidences of organ transplant failure and surgical reconstruction for cardiovascular diseases have raised the adoption of minimally invasive vascular implants, thereby boosting the demand for cardiac aneurysm products.

The vascular occlusion segment is expected to witness the fastest growth during the forecast period, owing to the increasing number of patients with vascular occlusion disease and the availability of procedures using grafts. Also, the treatment of vascular occlusion using synthetic grafts such as polytetrafluoroethylene (PTFE) is expected to impel market growth during the forecast period

Raw Material Insights

The Polytetrafluoroethylene segment held the market revenue share of 47.0% in 2023 owing to its advantages such as high patency rates, high-pressure tolerance, etc. Also, it adequately interacts with the tissue and is easy to use. Therefore, they are extensively used for peripheral bypass procedures and extra-anatomical surgeries. Moreover, technological modifications such as PTFE treated with argon plasma for the development of innovative products are expected to boost segment growth.

The polyester vascular graft segment is anticipated to register significant growth owing to the availability of raw materials and advantages such as durability and robustness. For instance, AbloGraft and Polyester Vascular Graft, offered by LeMaitre, are knitted and woven grafts that allow for deep penetration of bovine skin collagen and are manufactured with advanced sealant technology.

Moreover, due to the rise in the number of patients with vascular heart disease, the demand for functional polyester vascular grafts with small diameters has greatly increased, thereby positively impacting segment growth.

Regional Insights

North America held the largest market share of 35.0% in 2023, owing to the rising health awareness and availability of health care facilities for cardiovascular treatment in the region. Also, the availability of reimbursement policies and the adoption of advanced technological procedures are impelling market growth.

Furthermore, the use of biometric tools to accurately diagnose the disease and technological developments and discoveries of tissue-engineered products are impelling the growth of biomaterial vascular grafts. Furthermore, ongoing R&D for the development of grafts using advanced biomaterials is expected to drive the market over a forecast period.

However, Asia Pacific is expected to register the fastest growth during the forecast period. The region is heavily burdened by the increasing number of patients with cardiovascular diseases. Moreover, the population suffering from chronic kidney problems, end-stage heart disease, diabetes, etc. is anticipated to fuel market growth. In addition, the cardiac disorders leading to premature deaths are anticipated to foster market growth.

Some of the prominent players in the Vascular Grafts Market include:

• Medtronic plc
• Getinge AB
• LeMaitre Vascular, Inc.
• W. L. Gore and Associates, Inc.
• Cook Medical
• C. R. Bard
• Terumo Corporation
• Shanghai Suokang Medical Implants Co. Ltd.

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the global Vascular grafts market.

Product

• Hemodialysis Access Grafts
• Endovascular Stent Grafts
• Coronary Artery By-Pass Grafts
• Vascular Grafts for Aorta Disease
• Peripheral Vascular Grafts

Application

• Cardiac Aneurysm

• • Endovascular Stent Graft
  • Vascular Graft

• Kidney Failure
• Vascular Occlusion
• Coronary Artery Disease

Raw Material

• Polyester Vascular Grafts
• Polytetrafluoroethylene Vascular Grafts
• Polyurethane Vascular Grafts
• Biological Material-Based Vascular Grafts

• • Human Saphenous and Umbilical Veins
  • Tissue-engineered materials

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa (MEA)